Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
The prospects of minocycline in multiple sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
The gut microbiota and its correlations with the central nervous system disorders.
Impact of diagnosis and early treatment on the course of multiple sclerosis.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Pain and multiple sclerosis: pathophysiology and treatment.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
New technologies for biomarker discovery in multiple sclerosis.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Pages
« first
‹ previous
…
182
183
184
185
186
187
188
189
190
…
next ›
last »